ArticleCureus2026

Time to Screen for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Insights From a Single-Center Retrospective Risk Stratification Study in Saudi Arabia.

Turky Zahrani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.